QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NASDAQ:TARS

Tarsus Pharmaceuticals (TARS) Earnings Date, Estimates & Call Transcripts

$19.11
+0.33 (+1.76%)
(As of 06/7/2023 ET)
Compare
Today's Range
$18.70
▼
$19.78
50-Day Range
$11.57
▼
$18.78
52-Week Range
$11.33
▼
$19.78
Volume
434,816 shs
Average Volume
122,063 shs
Market Capitalization
$512.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$41.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 10Estimated
Actual EPS
(Mar. 13)
-$0.49 Beat By $0.48
Consensus EPS
(Mar. 13)
-$0.97
Last Year's Q1 EPS
(3/14/2022)
-$0.72
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

TARS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TARS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Tarsus Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($1.16)($0.88)($0.99)
Q2 20233($1.23)($1.08)($1.15)
Q3 20233($1.78)($1.15)($1.48)
Q4 20233($1.76)($1.12)($1.40)
FY 202312($5.93)($4.23)($5.02)

TARS Earnings Date and Information

Tarsus Pharmaceuticals last issued its earnings data on March 13th, 2023. The reported ($0.49) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.97) by $0.48. The firm had revenue of $10 million for the quarter, compared to analyst estimates of $11.67 million. Tarsus Pharmaceuticals has generated ($2.45) earnings per share over the last year (($2.45) diluted earnings per share). Earnings for Tarsus Pharmaceuticals are expected to grow in the coming year, from ($4.71) to ($3.36) per share. Tarsus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off prior year's report dates.

Tarsus Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2023
(Estimated)		        
3/13/2023Q4 2022($0.97)($0.49)+$0.48($0.49)$11.67 million$10.00 million
11/9/2022Q3 2022($0.98)($0.84)+$0.14($0.84)
8/11/2022Q2 2022($0.65)($0.24)+$0.41($0.24)$16.67 million$15.28 million
5/10/2022Q1 2022($0.87)($0.98)($0.11)($0.98)$5.50 million$0.54 million
3/14/2022Q4 2021($0.77)($0.72)+$0.05($0.72)$7.11 million$0.34 million
11/9/20219/30/2021($0.42)($0.76)($0.34)($0.76)$1.00 million$1.24 million
8/4/20216/30/2021($0.52)$0.29+$0.81$0.29$10.00 million$22.02 million
5/11/2021Q1 2021($0.64)$0.47+$1.11$0.47$33.43 million












Tarsus Pharmaceuticals Earnings - Frequently Asked Questions

When is Tarsus Pharmaceuticals's earnings date?

Tarsus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off last year's report dates. Learn more on TARS's earnings history.

Did Tarsus Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Tarsus Pharmaceuticals (NASDAQ:TARS) reported ($0.49) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.97) by $0.48. Learn more on analysts' earnings estimate vs. TARS's actual earnings.

How much revenue does Tarsus Pharmaceuticals generate each year?

Tarsus Pharmaceuticals (NASDAQ:TARS) has a recorded annual revenue of $25.82 million.

How much profit does Tarsus Pharmaceuticals generate each year?

Tarsus Pharmaceuticals (NASDAQ:TARS) has a recorded net income of -$62.09 million. TARS has generated -$2.45 earnings per share over the last four quarters.

What is Tarsus Pharmaceuticals's EPS forecast for next year?

Tarsus Pharmaceuticals's earnings are expected to grow from ($4.71) per share to ($3.36) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:TARS) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -